|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/444 | |
| A61K 31/4709 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2182948 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08786340.3 |
| Europos patento paraiškos padavimo data | 2008-07-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-05-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-03-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2008/059642 |
| Data | 2008-07-23 |
| (87) | Numeris | WO 2009/013305 |
| Data | 2009-01-29 |
| (30) | Numeris | Data | Šalis |
| 07112998 | 2007-07-24 | EP |
| (72) |
GARCIA-ECHEVERRIA, Carlos, CH
MAIRA, Sauveur-Michel, FR
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | USE OF IMIDAZOQUINOLINES FOR THE TREATMENT OF EGFR DEPENDENT DISEASES OR DISEASES THAT HAVE ACQUIRED RESISTANCE TO AGENTS THAT TARGET EGFR FAMILY MEMBERS |
| USE OF IMIDAZOQUINOLINES FOR THE TREATMENT OF EGFR DEPENDENT DISEASES OR DISEASES THAT HAVE ACQUIRED RESISTANCE TO AGENTS THAT TARGET EGFR FAMILY MEMBERS |